Back to Walleye Capital LLC Walleye Capital LLC

ZYMEZYME
Showing 8 of 11 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in Zymeworks Inc.

No. Walleye Capital exited its ZYME (Zymeworks) position in Q2 2026. Its Q1 2026 13F listed 78 shares worth $1,953. Walleye Capital first reported ZYME in Q3 2023 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$26.14
0
2026-Q1
Decreased
78
-99.4%
$1,9530.0%$24.45
0
2025-Q4
Increased
13,667
+179x
$359,8520.0%$26.54
38
2025-Q3
New
76
-
$1,2980.0%$17.23
17
2025-Q2
Exited
0
-100.0%
$00.0%$12.47
0
2025-Q1
Decreased
247,959
-45.2%
$3M0.0%$12.37
0
2024-Q4
New
452,804
-
$6.6M0.0%$14.51
38
2024-Q3
Exited
0
-100.0%
$00.0%$12.42
0

Other major holders of ZYME: BlackRock, Inc., Morgan Stanley

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used